Search results

From Self-sufficiency
Jump to: navigation, search
  • ...|author=Johnson JR, Manges AR, O'Bryan TT, Riley LW |title=A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis
    8 KB (1,056 words) - 20:12, 10 September 2010
  • Rifampicin [[antibiotic resistance|resistance]] develops quickly during treatment and rifampicin monotherapy should not b ...n combination with [[dapsone]] and [[clofazimine]] to avoid eliciting drug resistance.
    18 KB (2,471 words) - 16:43, 27 September 2010
  • ...treating severe, hospital-acquired infections with [[multidrug resistance|multidrug resistant]] [[Gram negative]] bacteria such as ''[[Pseudomonas aeruginosa]] ==Resistance==
    4 KB (498 words) - 16:44, 27 September 2010
  • ...o account [[CD4 count]], [[viral load|HIV viral load]], treatment history, resistance profiles and patient preference. ...e of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors | journal=Proc Natl Acad Sci USA | volume=99 |
    10 KB (1,441 words) - 16:45, 27 September 2010
  • ...as Invirase, a poorly-absorbed hard gel capsule which quickly led to viral resistance in many of the pioneer patients. The manufacturer, [[Hoffmann-La Roche|Roch ...lasma levels increased considerably. Additionally, ritonavir also inhibits multidrug transporters, although to a much lower extent.
    5 KB (717 words) - 15:07, 6 July 2010
  • ...]) for treating tuberculosis, but it is still useful in the treatment of [[multidrug-resistant tuberculosis]]. PAS is always used in combination with other anti ...eptomycin]], which had nerve toxicity and to which TB could easily develop resistance. Late in the 1940s, researchers at Britain's [[Medical Research Council (U
    7 KB (879 words) - 16:46, 27 September 2010
  • ...hps.scot.nhs.uk/ewr/pdf2003/0329.pdf |format=PDF }}</ref> due to bacterial resistance. Fluoroquinolones are no longer recommended in the USA for this indication. ...of ciprofloxacin in children should be restricted to infections caused by multidrug resistant pathogens or when no safe or effective alternatives are available
    88 KB (11,930 words) - 16:46, 27 September 2010
  • ...kshun, M. N. & Levy, S. B. Molecular Mechanisms of Antibacterial Multidrug Resistance. Cell, 128, 1037-1050 (2007).</ref> Resistance to tetracyclines can arise through drug [[efflux]], ribosomal protection pr
    11 KB (1,417 words) - 21:55, 19 September 2010
  • * Werle M, Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Rel 2006;111(
    4 KB (563 words) - 10:09, 20 September 2010
  • ...ody. Many types are difficult to attack with antibiotics, and [[antibiotic resistance]] is spreading to Gram-negative bacteria that can infect people outside the ...ges in Antibiotic Use Practices on Nosocomial Infections and Antimicrobial Resistance—''Clostridium difficile'' and Vancomycin-resistant Enterococcus (VRE) |ur
    25 KB (3,322 words) - 21:32, 20 September 2010
  • ...4161/cbt.4.4.1698 |author=Mei Y, Wei D, Liu J |title=Reversal of multidrug resistance in KB cells with tea polyphenol antioxidant capacity |journal=Cancer Biol.
    13 KB (1,796 words) - 21:29, 21 September 2010
  • ...ported from the brain by [[P-glycoprotein]] (Pgp), also known as multidrug resistance protein (MDR1). Tolerance in response to long-term use has not been report
    7 KB (989 words) - 22:12, 21 September 2010